{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:12:44Z","timestamp":1788988364875,"version":"build-2803163510"},"reference-count":16,"publisher":"Walter de Gruyter GmbH","issue":"2","funder":[{"name":"Zhuhai Science and Innovation Fund of China","award":["2220004000329"],"award-info":[{"award-number":["2220004000329"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_cclm-2025-0985_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>High-sensitivity cardiac troponin T (hs-cTnT) is used in pediatric healthcare to diagnose and assess the prognosis of various cardiac diseases, such as acute myocarditis, congenital heart disease, dilated cardiomyopathy, and heart failure. However, the standardized age-related reference intervals, 99th percentile cut-offs, and clinical guidelines are currently unavailable, especially in newborns and infants, making interpreting this biomarker challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2025-0985_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Residual serum samples were collected from 1,047 pediatric subjects with no cardiovascular disease, including 145 neonates and 902 infants. The concentrations of hs-cTnT were analyzed using Roche\u2019s Elecsys Troponin T hs assay. The age-related 99th percentile cut-offs with 90\u202f% confidence intervals (CIs) of hs-cTnT were established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2025-0985_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Subjects were divided into age subgroups as follows: newborns (0\u201330\u00a0days, n=142), infants aged 1\u00a0month (31\u201360\u00a0days, n=223), 2\u00a0months (61\u201390\u00a0days, n=152), 3\u20134\u00a0months (91\u2013150\u00a0days, n=211), 5\u20136\u00a0months (151\u2013210\u00a0days, n=149), and 7\u00a0months-1 year (211\u2013365\u00a0days, n=149). Serum hs-cTnT concentrations were highest during the first month of life and progressively declined in a year. The 99th percentile cut-offs of hs-cTnT concentration in each group were as follows: 114 (90\u202f% CI: 114-114), 65.6 (63.7\u201366.1), 55.2 (54.4\u201355.2), 30.4 (29.1\u201330.9), 23.5 (22.1\u201323.5), 12.7 (12.4\u201312.7) ng\/L. The 97.5th percentile cut-offs for each group were 109.4 (105.2\u2013114), 62.5 (60.5\u201363.9), 52.3 (50.3\u201354.4), 29 (28.5\u201329.1), 20.5 (19.2\u201323.4), and 12 (12\u201312.1)\u00a0ng\/L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2025-0985_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study aimed to provide reliable pediatric reference values for hs-cTnT based on a population of well-child children. These reference intervals and 99th percentile cut-offs will inform clinical decisions in the pediatric cardiology setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/cclm-2025-0985","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:57:06Z","timestamp":1758733026000},"page":"454-459","source":"Crossref","is-referenced-by-count":2,"title":["Establishing reference intervals for high-sensitivity cardiac troponin T in neonates and infants"],"prefix":"10.1515","volume":"64","author":[{"given":"Yue-Qi","family":"Li","sequence":"first","affiliation":[{"name":"Clinical Laboratory , Zhuhai Center for Maternal and Child Healthcare & Zhuhai Women and Children\u2019s Hospital , Zhuhai City , Guangdong Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Cheng","family":"Ye","sequence":"additional","affiliation":[{"name":"Clinical Laboratory , Boai Hospital of Zhongshan & Zhongshan Women and Children\u2019s Hospital , Zhongshan City , Guangdong Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ying","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory , Zhuhai Center for Maternal and Child Healthcare & Zhuhai Women and Children\u2019s Hospital , Zhuhai City , Guangdong Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong-Jun","family":"Tan","sequence":"additional","affiliation":[{"name":"Clinical Laboratory , Zhuhai Center for Maternal and Child Healthcare & Zhuhai Women and Children\u2019s Hospital , Zhuhai City , Guangdong Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"2026031918102569700_j_cclm-2025-0985_ref_001","doi-asserted-by":"crossref","unstructured":"Thygesen, K, Alpert, JS, Jaffe, AS, Chaitman, BR, Bax, JJ, Morrow, DA, et al.. Fourth universal definition of myocardial infarction. Circulation 2018;138:e618\u201351. https:\/\/doi.org\/10.1161\/cir.0000000000000617.","DOI":"10.1161\/CIR.0000000000000617"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_002","doi-asserted-by":"crossref","unstructured":"Cullen, LA, Mills, NL, Mahler, S, Body, R. Early rule-out and rule-in strategies for myocardial infarction. Clin Chem 2017;63:129\u201339. https:\/\/doi.org\/10.1373\/clinchem.2016.254730.","DOI":"10.1373\/clinchem.2016.254730"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_003","doi-asserted-by":"crossref","unstructured":"Wu, AHB, Christenson, RH, Greene, DN, Jaffe, AS, Kavsak, PA, Ordonez-Llanos, J, et al.. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the academy of the American association for clinical chemistry and the task force on clinical applications of cardiac bio-markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem 2018;64:645\u201355. https:\/\/doi.org\/10.1373\/clinchem.2017.277186.","DOI":"10.1373\/clinchem.2017.277186"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_004","doi-asserted-by":"crossref","unstructured":"Bohn, MK, Higgins, V, Kavsak, P, Hoffman, B, Adeli, K. High-sensitivity generation 5 cardiac troponin T Sex and age-specific 99th percentiles in the CALIPER cohort of healthy children and adolescents. Clin Chem 2019;65:589\u201391. https:\/\/doi.org\/10.1373\/clinchem.2018.299156.","DOI":"10.1373\/clinchem.2018.299156"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_005","doi-asserted-by":"crossref","unstructured":"Lam, E, Higgins, V, Zhang, L, Chan, MK, Bohn, MK, Trajcevski, K, et al.. Normative values of high-sensitivity cardiac troponin T and N-Terminal pro-B-Type natriuretic peptide in children and adolescents: a study from the CALIPER cohort. J\u00a0Appl Lab Med 2021;6:344\u201353. https:\/\/doi.org\/10.1093\/jalm\/jfaa090.","DOI":"10.1093\/jalm\/jfaa090"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_006","doi-asserted-by":"crossref","unstructured":"Guo, Q, Yang, D, Zhou, Y, Zhang, S, Zhu, T, Wang, A, et al.. Establishment of the reference interval for high-sensitivity cardiac troponin T in healthy children of Chongqing Nan\u2019an district. Scand J Clin Lab Invest 2021;81:579\u201384. https:\/\/doi.org\/10.1080\/00365513.2021.1979245.","DOI":"10.1080\/00365513.2021.1979245"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_007","doi-asserted-by":"crossref","unstructured":"Shen, H, Jiang, L, Ji, J, Wang, C, Ju, Q, Zhao, Y, et al.. Age-specific reference values for the 5th generation cardiac troponin T assay in Chinese children. Medicine (Baltimore) 2022;101:e29101. https:\/\/doi.org\/10.1097\/md.0000000000029101.","DOI":"10.1097\/MD.0000000000029101"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_008","doi-asserted-by":"crossref","unstructured":"Kiess, A, Green, J, Willenberg, A, Ceglarek, U, D\u00e4hnert, I, Jurkutat, A, et al.. Age-dependent reference values for hs-Troponin T and NT-proBNP and determining factors in a cohort of healthy children (the LIFE child study). Pediatr Cardiol 2022;43:1071\u201383. https:\/\/doi.org\/10.1007\/s00246-022-02827-x.","DOI":"10.1007\/s00246-022-02827-x"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_009","doi-asserted-by":"crossref","unstructured":"McEvoy, JW, Wang, D, Brady, T, Tang, O, Ndumele, CE, Coresh, J, et al.. Myocardial injury thresholds for 4\u00a0high-sensitivity troponin assays in a population-based sample of US children and adolescents. Circulation 2023;148:7\u201316. https:\/\/doi.org\/10.1161\/circulationaha.122.063281.","DOI":"10.1161\/CIRCULATIONAHA.122.063281"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_010","doi-asserted-by":"crossref","unstructured":"Zhang, X, Han, X, Zhao, M, Mu, R, Wang, S, Yun, K, et al.. Determination of high-sensitivity cardiac troponin T upper reference limits under the improved selection criteria in a Chinese population. J\u00a0Clin Lab Anal 2020;34:e23007. https:\/\/doi.org\/10.1002\/jcla.23007.","DOI":"10.1002\/jcla.23007"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_011","doi-asserted-by":"crossref","unstructured":"Apple, FS, Wu, AHB, Sandoval, Y, Sexter, A, Love, SA, Myers, G, et al.. Sex-specific 99th percentile upper reference limits for high sensitivity cardiac troponin assays derived using a universal sample bank. Clin Chem 2020;66:434\u201344. https:\/\/doi.org\/10.1093\/clinchem\/hvz029.","DOI":"10.1093\/clinchem\/hvz029"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_012","doi-asserted-by":"crossref","unstructured":"Aakre, KM, Meex, SJR, Mills, NL. Cardiac troponin reporting in children and young adults: time to change clinical practice. Circulation 2023;148:17\u201319. https:\/\/doi.org\/10.1161\/circulationaha.123.065297.","DOI":"10.1161\/CIRCULATIONAHA.123.065297"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_013","doi-asserted-by":"crossref","unstructured":"Borensztajn, DM, Tan, CD, de Rijke, Y, Hagedoorn, NN, Verbruggen, SC, Moll, HA, et al.. Elevated high-sensitivity troponin and NT-proBNP values in febrile children. Pediatr Emerg Care 2024;40:108\u201313. https:\/\/doi.org\/10.1097\/pec.0000000000003097.","DOI":"10.1097\/PEC.0000000000003097"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_014","doi-asserted-by":"crossref","unstructured":"Zhang, Y, Cao, Y, Xin, Y, Liu, Y. Significance of detecting cardiac troponin I and creatine kinase MB in critically ill children without primary cardiac illness. Front Pediatr 2024;12:1445651. https:\/\/doi.org\/10.3389\/fped.2024.1445651.","DOI":"10.3389\/fped.2024.1445651"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_015","doi-asserted-by":"crossref","unstructured":"Bohn, MK, Steele, S, Hall, A, Poonia, J, Jung, B, Adeli, K. Cardiac biomarkers in pediatrics: an undervalued resource. Clin Chem 2021;67:947\u201358. https:\/\/doi.org\/10.1093\/clinchem\/hvab063.","DOI":"10.1093\/clinchem\/hvab063"},{"key":"2026031918102569700_j_cclm-2025-0985_ref_016","doi-asserted-by":"crossref","unstructured":"Zrinski Topic, R, Lenicek Krleza, J. Cardiac markers in pediatric laboratory medicine: critical review. Diagnostics (Basel) 2025;15:165. https:\/\/doi.org\/10.3390\/diagnostics15020165.","DOI":"10.3390\/diagnostics15020165"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0985\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0985\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:12:29Z","timestamp":1773943949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0985\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,9,12]]},"published-print":{"date-parts":[[2026,1,29]]}},"alternative-id":["10.1515\/cclm-2025-0985"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2025-0985","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]}}}